Capital Expenditures - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Capital Expenditures Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Capital Expenditures
-€10k
CAGR 3-Years
-19%
CAGR 5-Years
58%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Capital Expenditures
-€11.3m
CAGR 3-Years
42%
CAGR 5-Years
-13%
CAGR 10-Years
-8%
Nanobiotix SA
PAR:NANO
Capital Expenditures
-€337k
CAGR 3-Years
-47%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Capital Expenditures
-€2.3m
CAGR 3-Years
-9%
CAGR 5-Years
49%
CAGR 10-Years
0%
Genfit SA
NASDAQ:GNFT
Capital Expenditures
-€2.5m
CAGR 3-Years
-40%
CAGR 5-Years
3%
CAGR 10-Years
-26%
Eurobio Scientific SA
PAR:ALERS
Capital Expenditures
-€4.1m
CAGR 3-Years
-21%
CAGR 5-Years
-20%
CAGR 10-Years
-22%

See Also

What is Gensight Biologics SA's Capital Expenditures?
Capital Expenditures
-10k EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Capital Expenditures amounts to -10k EUR.

What is Gensight Biologics SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
58%

Over the last year, the Capital Expenditures growth was 96%. The average annual Capital Expenditures growth rates for Gensight Biologics SA have been -19% over the past three years , 58% over the past five years .

Back to Top